z-logo
open-access-imgOpen Access
A case of lafora disease diagnosed by axillary skin biopsy
Author(s) -
Elife Kımıloğlu,
Pelin Akbas,
Ozgul Esen Ore,
Çağla TURAN
Publication year - 2021
Publication title -
turkish journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.305
H-Index - 14
eISSN - 1309-5730
pISSN - 1018-5615
DOI - 10.5146/tjpath.2021.01522
Subject(s) - lafora disease , biopsy , skin biopsy , medicine , myoclonus , differential diagnosis , pathology , apocrine , dermatology , epilepsy , eccrine sweat gland , brain biopsy , progressive myoclonus epilepsy , disease , axilla , sweat gland , biology , sweat , anesthesia , psychiatry , biochemistry , phosphorylation , cancer , breast cancer , phosphatase
Lafora disease is a severe form of progressive myoclonic epilepsy with autosomal recessive inheritance diagnosed by inclusion body in biopsy. A 26-year-old woman was admitted due to complaints of frequent twitches and fainting. The 0.5x0.3x0.3 cm axillary skin punch biopsy was subjected to routine histopathological evaluation. Cytoplasmic PAS-positive inclusion bodies were observed at the basal side of the eccrine and apocrine glands. The diagnosis of Lafora disease can also be made by the observation of the polyglycosan cytoplasmic inclusion bodies in the brain, liver and skeletal muscle biopsies. Although we need more work to understand the etiopathogenesis of Lafora disease, we would like to draw attention to the importance of skin biopsy in the differential diagnosis of young patients with clinically refractory epilepsy, myoclonus, and cognitive decline.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom